Therapeutic Action
Anticholinergic antiparkinson drug
PDF page 319
Loading InternPractice…
Drug reference
Anticholinergic antiparkinson drug
PDF page 319
Second-line treatment of extrapyramidal reactions induced by antipsychotics
PDF page 319
Do not administer to patients with closed-angle glaucoma, prostate disorders, gastrointestinal obstruction or atony. Administer with caution and carefully monitor use in elderly patients (risk of mental confusion, hallucinations). May cause: anticholinergic effects (dry mouth, constipation, blurred vision, tachycardia, disorders of micturition), confusion, hallucinations, memory loss. Avoid or monitor combination with other anticholinergic drugs (atropine, amitriptyline, chlorpromazine, promethazine, etc.). Pregnancy: re-evaluate whether the antipsychotic treatment is still necessary; if treatment is continued, administer trihexyphenidyl at the lowest effective dose; observe the neonate if the rd mother was under treatment in the 3 trimester (risk of anticholinergic effects, e.g. tremors, abdominal distension). Breast-feeding: if treatment is necessary, administer at the lowest effective dose and observe the child (risk of anticholinergic effects, e.g. tachycardia, constipation, thickening of bronchial secretions).
PDF pages 319, 320
2 mg tablet
PDF page 319
Adult: 2 mg once daily, then increase if necessary up to 2 mg 2 or 3 times daily (max. 12 mg daily) Administer the lowest effective dose in elderly patients and do not exceed 10 mg daily.
PDF page 319
As long as antipsychotic treatment lasts.
PDF page 319
Take with meals. Also comes in 2 mg extended-release capsule, administered once daily. Trihexyphenidyl is also used in treatment of Parkinson’s disease.
PDF page 320
– – Below 25 °C
PDF page 320
2 mg once daily, then increase if necessary up to 2 mg 2 or 3 times daily (max. 12 mg daily)
PDF page 319